A population-based study of mortality among patients with atrial fibrillation or flutter.
about
Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-AnalysisLeft atrial pathological degeneration assessed by integrated backscatter transesophageal echocardiography as a predictor of progression to persistent atrial fibrillation: results from a prospective study of three-years follow-up.Atrial tachyarrhythmias in primary and secondary prevention ICD recipients: clinical and prognostic data.Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort.Atrial flutter: from ECG to electroanatomical 3D mapping.Measuring disease frequency in the Marshfield Epidemiologic Study Area (MESA)Atrial flutter versus atrial fibrillation in a general population: differences in comorbidities associated with their respective onset.Association of B-type natriuretic Peptide levels with estimated glomerular filtration rate and congestive heart failure.Sudden flare of rheumatoid arthritis associated with newly diagnosed atrial flutter.Evaluation of left atrial volume and function using single-beat real-time three-dimensional echocardiography in atrial fibrillation patients.Preoperative arrhythmias such as atrial fibrillation: cardiovascular surgery risk factor.Impact of age, CYP2C9 genotype and concomitant medication on the rate of rise for prothrombin time during the first 30 days of warfarin therapy.Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation.Improved detection of paroxysmal atrial fibrillation utilizing a software-assisted electrocardiogram approach.Atrial fibrillation: epidemiologic considerations and rationale for conversion and maintenance of sinus rhythm.Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registryNewly diagnosed atrial fibrillation is an independent factor for future major adverse cardiovascular eventsOne-year safety and quality of life outcomes in patients with atrial fibrillation on dronedarone: prospective, non-interventional study in German ambulatory care.How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era?Rate control vs. rhythm control in the management of atrial fibrillation in elderly persons.Clinical considerations of anticoagulation therapy for patients with atrial fibrillationFindings of transoesophageal echocardiogram in appropriately anticoagulated patients with persistent atrial fibrillation prior to planned cardioversion.Left atrial mechanical function and stiffness in patients with paroxysmal atrial fibrillation.Atrial conduction time, and left atrial mechanical and electromechanical functions in patients with polycystic ovary syndrome: interatrial conduction delay.Novel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patientAll-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control studySpinal cord stimulation protects against atrial fibrillation induced by tachypacing.Incidence of left atrial abnormalities under treatment with dabigatran, rivaroxaban, and vitamin K antagonists.The Role Of Renin Angiotensin System In Atrial Fibrillation.Exploring the Potential Role of Catheter Ablation in Patients with Asymptomatic Atrial Fibrillation: Should We Move away from Symptom Relief?Importance of atrial surface area and refractory period in sustaining atrial fibrillation: testing the critical mass hypothesis.Assessment of atrial electromechanical interval and P wave dispersion in patients with polycystic ovary syndrome.Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation.Effect of telmisartan on atrial fibrillation recurrences in patients with hypertension: a systematic review and meta-analysis.The M235T polymorphism in the angiotensinogen gene and atrial fibrillation: A meta-analysis.Atrial flutter and thromboembolic risk: a systematic review.Death and thrombo-embolic risk after ablation of atrial flutter compared with atrial fibrillation: a nationwide cohort study.Demographics, treatment and outcomes of atrial fibrillation in a developing country: the population-based TuRkish Atrial Fibrillation (TRAF) cohort.Monitoring Atrial Fibrillation After Catheter Ablation.Educational inequalities in mortality of patients with atrial fibrillation in Norway.
P2860
Q28085676-93E76DDC-4C88-4411-A79C-EFB30CD328D9Q30464769-7D4F7707-33D6-4DED-8863-F90EE6895209Q31085565-52D9CC29-4C9F-46F5-A869-EA7CD7AD7F9AQ31110501-BCC63BDA-592A-4191-952E-4629C1428341Q33160528-529F33B7-00CF-4D5F-80AB-F137BAE13996Q33723434-E2DB906D-36D7-49CF-A83E-B1B8E7E7948AQ33741873-825140B4-5BC0-487E-9C90-129A2317037BQ33741915-4F152A4D-138A-49F0-AFB5-505F4A2B7C7AQ33763052-56593120-8320-41FF-AB53-BA7951CC65CEQ33922692-B7876A5D-3624-45CF-A6F3-12FB4996A2EDQ33930278-7931B145-8715-45FE-8B6B-22E9CCB8C07FQ34146486-71250E64-0035-4A6F-AEC6-21DA64134670Q35018887-F8D41F16-2BEB-4BD9-968A-A9C733C21F9AQ35107066-58234A5F-003B-419A-8288-791C9ECAFA42Q35127391-EC1167AB-1248-45AA-86F0-921977687185Q35226363-F6ADB025-B4B1-426B-8EA7-608ABBADD545Q35432867-5A1FAF1C-F0FB-45AF-8FAD-9570A7F4B8D9Q35782224-8AE6630A-1D4A-43A4-9EC6-A87615477BA3Q36021753-9E3DE971-8022-4C37-8152-26353DF2CB4FQ36077780-F1079019-64E2-4536-B313-EFAC87A7B34DQ36137613-D7C5090E-7A20-4E5F-9BE7-680D736B26CAQ36287783-9B24BCBD-B3D2-43F2-928E-7AC2AE729032Q36399390-42B90019-3AB2-4787-AC2F-DAAC542691B5Q36656901-22ABB7CF-E5E6-4E90-B27B-15255DB85D39Q36723401-9C528D65-4BEF-41AC-9C1B-42043E242254Q36746225-DB103798-F075-42AC-8B3B-9694CC7A7837Q36789325-0E6BD2D1-1552-44BF-B723-AC38A2EB672EQ37355781-55D08941-D142-4D26-8CAE-BC9E3F369882Q37469038-8B6B0C93-530F-4138-B516-43148EF2ABADQ37495738-DF41D05D-8D4A-450D-841E-229BECA0A7A0Q37663680-5990D78D-0215-461A-81AC-AAE6566A0BE6Q37680264-EF406E79-DE29-4BB9-A146-B1529B827A2AQ38151988-64F63875-C221-41F0-8AD5-EA0D1DADEBE1Q38197227-6ABE4FB7-6560-4175-8512-135C0B68F9CEQ38395304-383BAFB1-DC17-42CB-BF94-B5FD51ACCDCEQ38543378-0512AC5B-4A74-498B-8AEC-2EE19DD60C53Q38811932-A88D7F8D-4D95-4FA9-A697-F4BCD31ED0CEQ38967685-F7D17630-6B7B-4EA3-A522-16057F5174A6Q39036947-9467C6E2-307F-4519-931F-04148E38EAD0Q39130676-B9A4BC89-EE39-40EF-92B1-E0E37F6A8C48
P2860
A population-based study of mortality among patients with atrial fibrillation or flutter.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A population-based study of mortality among patients with atrial fibrillation or flutter.
@ast
A population-based study of mortality among patients with atrial fibrillation or flutter.
@en
A population-based study of mortality among patients with atrial fibrillation or flutter.
@nl
type
label
A population-based study of mortality among patients with atrial fibrillation or flutter.
@ast
A population-based study of mortality among patients with atrial fibrillation or flutter.
@en
A population-based study of mortality among patients with atrial fibrillation or flutter.
@nl
prefLabel
A population-based study of mortality among patients with atrial fibrillation or flutter.
@ast
A population-based study of mortality among patients with atrial fibrillation or flutter.
@en
A population-based study of mortality among patients with atrial fibrillation or flutter.
@nl
P2093
P1476
A population-based study of mortality among patients with atrial fibrillation or flutter.
@en
P2093
Humberto Vidaillet
John Hayes
Juan F Granada
Juan N Pulido
Karen Maassen
Mario Ortiz
P o-Huang Chyou
Param Sharma
Peter N Smith
P304
P356
10.1016/S0002-9343(02)01253-6
P407
P577
2002-10-01T00:00:00Z